Applied Behavior Analysis for the Treatment of Autism
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Iowa policy alerts
Know when Blue Cross Blue Shield - Iowa releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage and medical necessity criteria for outpatient and embedded inpatient/residential/partial hospitalization applied behavior analysis (ABA) therapy for members with autism spectrum disorder (ASD) under Blue Cross Blue Shield - Iowa/Wellmark plans; it affects providers requesting prior authorization and members seeking ABA services for ASD.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
inv-01: Initial ABA treatment assessment
Covered when ALL of the following are met:
inv-02: Initiation of ABA services
Covered when ALL of the following are met:
For comprehensive treatment, goals target narrowing the developmental/chronological age gap; for focused treatment, goals target selected symptoms and appropriate alternatives.
inv-03: Continuation criteria
Covered when ALL of the following are met:
If successive authorization periods fail to show measurable progress, coverage may be reduced or denied.
Recommended caregiver training dosing described in policy.
inv-03: Continuation, Discharge, Resumption, and NMN criteria for ABA
Covered when ALL of the following are met (for resumption) or for continuation; discharge rules and examples of not medically necessary conditions are also provided:
Initiation criteria referenced elsewhere in policy.
Examples are not exhaustive.
inv-05: Clinical context and treatment selection
Covered when ABA is selected as a treatment option for children with ASD based on individualized assessment and matching of treatment intensity/model to needs:
inv-06: Evidence synthesis (meta-analyses and RCTs)
Evidence summary relevant to coverage:
inv-07: Evidence Summary - Children
Covered when evidence supports improvement in specified outcomes with documentation:
Source: Rogers et al and Eckes et al meta-analyses.
inv-08: Evidence Summary - Adults
Covered when evidence demonstrates clinically meaningful functional improvement; current evidence is limited:
Coverage for adults should require stronger documentation of expected functional benefit.
ABA therapy provided for indications other than treatment of autism spectrum disorder (ASD) is considered a non-covered benefit. Services that duplicate or replace educational programming, are provided as part of a school or educational setting, or are the responsibility of the educational system are not covered. Coverage also is not available when the treatment does not meet clinical appropriateness for type, frequency, extent, site, or duration, or when the member does not have a diagnosis of ASD.
Telehealth/telemedicine is not an approved method for delivery of direct ABA services listed as direct adaptive behavior treatment codes (for example, 97153, 97154, 0373T). Telehealth may be used for parent education or family guidance (97156, 97157) and for direct supervision activities (97155) only if the member's benefit plan allows such telehealth services, and it is recommended that telehealth be combined with face-to-face supervision when used.
Applied behavior analysis (ABA) is not regulated by the U.S. Food and Drug Administration; therefore, no FDA-based regulatory exclusions apply to ABA therapy.
Interventions for which comparative evidence demonstrating clinically important improvements in functional outcomes is lacking—particularly for adults with ASD—are not well supported. For children, meta-analyses and RCTs provide some evidence of benefit for early intensive ABA, but studies have limitations and longer-term comparative data are needed. For adults, the evidence consists mainly of single-case reports and small series, and controlled studies reporting clinically important functional outcomes are lacking.
Within this portion of the policy there are no additional explicit exclusion conditions listed beyond those identified elsewhere in the document.
While caregiver involvement and training are expected components of ABA programs, participation in parent support groups is considered not medically necessary and is not a covered clinical service.
ABA provided solely to achieve non-specific behavioral improvement or as generalized supportive care—rather than as a time-limited, goal-directed intervention—is considered not medically necessary. Services primarily for social skills training, high-level social discourse, or when a less intensive level of service would likely produce equivalent therapeutic results also are listed as not medically necessary examples.
Studies with low methodological quality, high risk of bias, or duplicative/overlapping populations were excluded from efficacy assessments; such limitations reduce the credibility of evidence and constrain conclusions about benefit for specific ABA interventions.
ABA interventions for adults lack controlled trials demonstrating improvements in clinically important functional outcomes; absent documentation of expected functional benefit or controlled-study support, requests for adult ABA may be considered not medically necessary pending stronger evidence.
In the excerpt reviewed there are no explicit statements labeled 'not medically necessary' beyond the examples and conditions already described elsewhere in the policy.
CPT/HCPCS and Billing Codes
| 97153 | Direct ABA service (documented in policy as example of direct service not approved via telehealth) |
| 97154 | Direct ABA service (documented in policy as example of direct service not approved via telehealth) |
| 0373T | ABA CPT Category III code (listed as direct ABA service not approved via telehealth) |
| 97156 | Parent education (telehealth may be allowed per benefit plan) |
| 97157 | Family/caregiver training (telehealth may be allowed per benefit plan) |
| 97155 | Direct supervision (telehealth may be allowed per benefit plan) |
| 97153 | Direct ABA service (documented in policy as an example of direct ABA codes for which telehealth is not approved) |
| 97154 | Group or other direct ABA service (listed as direct ABA code for telehealth limitation) |
| 0373T | Temporary CPT Category III code cited as direct ABA code (telehealth not approved) |
| 97156 | Parent education/intervention (telehealth may be allowed if plan permits) |
| 97157 | Family adaptive behavior treatment guidance (telehealth may be allowed if plan permits) |
| 97155 | Direct supervision of ABA (telehealth may be allowed if plan permits) |
| 97151 | Behavior identification assessment, administered by a physician or other qualified health care professional, each 15 minutes of the physician's or other qualified health care professional's time face-to-face with patient and/or guardian(s)/caregiver(s) administering assessments and discussing findings and recommendations, and non-face-to-face analyzing past data, scoring/interpreting the assessment, and preparing the report/treatment plan. |
| 97152 | Behavior identification-supporting assessment, administered by one technician under the direction of a physician or other qualified health care professional, face-to-face with the patient, each 15 minutes. |
| 97153 | Adaptive behavior treatment by protocol, administered by technician under the direction of a physician or other qualified health care professional, face-to-face with one patient, each 15 minutes. |
| 97154 | Group adaptive behavior treatment by protocol, administered by technician under the direction of a physician or other qualified health care professional, face-to-face with two or more patients, each 15 minutes. |
| 97155 | Adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, which may include simultaneous direction of technician, face-to-face with one patient, each 15 minutes. |
| 97156 | Family adaptive behavior treatment guidance, administered by physician or other qualified health care professional (with or without the patient present), face-to-face with guardian(s)/caregiver(s), each 15 minutes. |
| 97157 | Multiple-family group adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of guardians/caregivers, each 15 minutes. |
| 97158 | Group adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, face-to-face with multiple patients, each 15 minutes. |
| 0362T | Behavior identification supporting assessment, each 15 minutes of technicians' time face-to-face with a patient, requiring the following components: administration by the physician or other qualified health care professional who is on site; with the assistance of two or more technicians; for a patient who exhibits destructive behavior; completion in an environment that is customized to the patient's behavior. |
| 0373T | Adaptive behavior treatment with protocol modification, each 15 minutes of technicians' time face-to-face with a patient, requiring the following components: administration by the physician or other qualified health care professional who is on site; with the assistance of two or more technicians; for a patient who exhibits destructive behavior; completion in an environment that is customized to the patient's behavior. |
Authorization, Documentation, and Submission Requirements
Reduction or denial for lack of progress
If the individual does not demonstrate significant improvement or progress achieving goals for successive authorization periods, benefit coverage of ABA services may be reduced or denied. Continuation requests must demonstrate measurable progress; lack of progress is a common denial trigger.
- Reduction/denial may occur when there is no clinically significant improvement over successive authorization periods.
- Coverage may be reduced or denied if goals are not met or measurable progress toward goals is insufficient.
Discharge / Not continued
ABA services should be discontinued when discharge criteria are met. Examples include achievement of treatment goals or maximum benefit, caregiver refusal or inability to participate to a degree that compromises effectiveness, treatment exacerbating behaviors, or lack of continued benefit.
- Discharge when goals are achieved or maximum benefit reached.
- Discharge when caregivers refuse or cannot participate, compromising treatment.
- Discharge when treatment exacerbates behavioral issues or individual is unlikely to maintain gains.
Studies with duplicative or overlapping populations
Studies with duplicative or overlapping populations were excluded during evidence selection. Provide study-level clinical documentation when submitting requests; avoid relying on duplicate datasets.
- Study selection excluded duplicative or overlapping populations.
- When referencing evidence in requests, supply source-level details (population, duration, outcomes).
Evidence insufficiency risk
Evidence supporting requests should include validated outcome measures, duration/intensity of intervention, and study-level details demonstrating clinical benefit. Requests based on limited, short-term, or heterogeneous evidence carry an evidence insufficiency risk.
- Provide validated outcome measures (e.g., VABS, IQ, ABLLS, VB-MAPP).
- Describe intervention intensity/duration and comparator used.
- Note that some meta-analyses show benefit but also substantial heterogeneity and limited long-term follow-up.
Supervision and caregiver training documentation
Documentation must include evidence of onsite supervision and caregiver training. Supervision and caregiver training are required components of the treatment plan and must be documented, including assessment of caregiver skills, measurable caregiver goals, and monitoring of caregiver implementation.
- Document onsite supervision of ABA (who supervised, frequency, and activities).
- Include caregiver training assessment, goals, mastery criteria, and documentation of caregivers' ability to implement procedures.
- Caregiver participation is expected for at least 80% of agreed sessions; recommended caregiver training hours: 1 hour per first 10 direct therapy hours, plus 0.5 hours per additional 10 hours (unless contraindicated or declined).
Supporting evidence for requests
Provide supporting evidence with the prior approval request: comprehensive assessments (ABLLS, VB-MAPP or equivalent), baseline data, progress graphs, adaptive behavior testing (annual VABS/ABAS), and a treatment plan tying intensity/hours to behavioral targets.
- Submit initial and ongoing assessments (ABLLS, VB-MAPP, VABS, ABAS, PDDBI) and baseline measures.
- Include collected data: progress charts, celebration charts, and clinical notes linking interventions to goals.
- Justify hours requested per behavioral target and explain how intensity represents least restrictive treatment.
Use of listed CPT/HCPCS codes
Report services using the listed CPT and HCPCS codes. Use appropriate diagnosis codes and revenue codes when submitting claims. Failure to use correct CPT/HCPCS/Revenue/ICD codes may trigger processing delays or denials.
ABA treatment models vary
ABA treatment models vary from focused to comprehensive. Specify which model is being used, number and type of targeted domains, and rationale for chosen intensity (focused = limited targets; comprehensive = multiple developmental domains).
- Indicate whether treatment is focused (limited behavioral targets or acute problem behavior) or comprehensive (multiple developmental domains).
- Tie the chosen model to the individual's needs and the proposed hours of service.
- Describe plans for integrating structured sessions with naturalistic methods and for stepping down services over time.
Comparator therapies
List and address comparator therapies in the medical record. Comparators include standard clinical care such as behavioral, developmental, educational, pharmacological, psychological, and complementary/alternative approaches; documentation should explain why ABA is medically necessary relative to these alternatives.
- Document other services the individual is receiving (speech, OT, PT, school-based services) and ensure ABA does not duplicate educational services.
- Explain why ABA is preferred or necessary compared with other behavioral/clinical options.
- If ABA would duplicate services available through educational settings, coverage may be denied.
Clinical Background and Evidence
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder characterized by persistent deficits in social communication and restricted/repetitive behaviors. Applied behavior analysis (ABA) uses behavioral techniques to teach communication, adaptive skills, and social interaction and may be delivered or supervised by licensed clinicians or BACB‑certified providers. Evidence in preschool children includes meta-analytic and randomized trial data showing some improvements in adaptive behavior and cognition at about 2 years, though study limitations and short follow-up temper conclusions; evidence for adults is limited to case reports and small series and requires further comparative research to establish clinically meaningful functional benefits.
inv-06: Evidence synthesis (meta-analyses and RCTs)
Evidence summary relevant to coverage:
inv-07: Evidence Summary - Children
Covered when evidence supports improvement in specified outcomes with documentation:
inv-08: Evidence Summary - Adults
Covered when evidence demonstrates clinically meaningful functional improvement; current evidence is limited:
inv-68: Supporting evidence and trials
References and ongoing trials relevant to ABA effectiveness and practice guidelines are provided to support clinical decision-making:
Definitions and Roles
Level of Care and Setting
ABA-specific Clinical Criteria
inv-63: ABA clinical coverage nodes
ABA-specific coverage criteria and requirements:
inv-64: ABA-specific clinical criteria and expectations
Criteria and treatment model considerations specific to ABA:
When mastery criteria modified to incremental objectives, overall goal is considered continued.
Recommended caregiver training dosing: 1 hour per first 10 hours of direct therapy plus 0.5 hours per additional 10 hours unless contraindicated or declined.
Intensity measured in hours/week and informs model selection.
inv-65: ABA service components
Treatment and service delivery expectations for ABA:
Caregiver training should include measurable goals, modeling, supervised practice, and coaching.
inv-66: ABA Clinical Criteria - Pediatrics
Clinical guidance and evidence summary for ABA use:
Reflects AAP guidance and meta-analytic findings.
inv-67: ABA Clinical Criteria - Adults
Adult ABA considerations:
Summarized from systematic review and case series.
inv-68: Supporting evidence and trials
Supporting evidence and trials relevant to ABA effectiveness and practice guidelines are listed to support clinical decision-making:
Delivery Modalities and Treatment Models
inv-69: Telehealth for ABA
Telehealth limits for ABA:
inv-70: ABA models
ABA treatment models:
inv-71: ABA (Focused, Comprehensive)
Focused and comprehensive ABA distinctions:
Intensity and duration vary by need.
inv-72: Applied Behavior Analysis techniques
Common ABA techniques observed in studies and case series:
inv-73: Applied Behavior Analysis (ABA)
Service delivery modalities represented by listed CPT/HCPCS codes:
Specific service delivery requirements (e.g., on-site physician for certain temporary codes) are included in code descriptions.
Authorization Intervals, Intensity, and Visit Limits
Policy Revision History
December 2025 annual review conducted and policy revised.
December 2024 annual review conducted and policy revised.
December 2023 annual review conducted and policy revised.
December 2022 annual review conducted and policy renewed.
December 2021 annual review conducted and policy revised.
March 2021 interim review conducted and policy revised.
December 2020 annual review conducted and policy renewed.
May 2020 interim review conducted and policy revised.
February 2020 interim review conducted and policy revised.
December 2019 annual review conducted and policy revised.
December 2018 annual review conducted and policy renewed.
December 2017 annual review conducted and policy revised.
March 2017 interim review conducted and policy revised.
January 2017 interim review conducted and policy revised.
December 2016 interim review and new policy created.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.